Iressa Expanded Access Program (EAP)

Clinical trial NCT00034879 · COMPLETED

Trial details

NCT number: NCT00034879
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma Non-small-cell Lung Metastases Neoplasm

Start date: 2000-08-01
Primary completion: 2003-10-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.